Vapotherm Inc Closes $20 Million Series C Financing Round - Gilde Healthcare

Vapotherm Inc Closes $20 Million Series C Financing Round

13. März 2015

EXETER, NH – Vapotherm, Inc., a developer and manufacturer of advanced respiratory care technology, today announced the closing of a $20MM equity financing. 3×5 Specialty Opportunity Fund led the financing round, which also included current investors QuestMark Partners, Gilde Healthcare Partners, Morgenthaler Ventures, Kaiser Permanente, Adage Capital Management, Crestline Investors and Cross Creek Capital.

Tony Arnerich General Partner of 3×5 Special Opportunity Fund commented: “We are excited about Vapotherm’s unique High Flow Therapy solution which improves clinical outcomes for patients with chronic and acute breathing disorders.”

“This new capital will be used to continue to build out our direct sales organization in the U.S. and to develop our next generation solutions. We appreciate the continued support of our investors as we build a leading respiratory care company,” said Joe Army, President and CEO of Vapotherm.

Vapotherm, Inc. is a privately held developer and manufacturer of advanced respiratory care technology based in Exeter, New Hampshire. The company develops innovative, comfortable, noninvasive technologies for respiratory support of patients with chronic or acute breathing disorders. Over 700,000 patients have been treated with Vapotherm High Flow Therapy. For more information, visit www.vtherm.com.

Contact: John Landry, VP & CFO
T: (603) 658-0011

Gilde Healthcare company Moximed raises $40 Million to advance world’s first Implantable Shock Absorber for Knee Osteoarthritis

Moximed, a medical device company on a mission to improve the standard of care for people with knee osteoarthritis (OA), today announced $40 million in Series C equity and debt financing. The round was led...
16. August 2022

Gilde Healthcare company Nalu appoints Thomas West as new president and CEO

Nalu Medical, Inc. (“Nalu”), a private company focused on innovative and minimally invasive solutions for chronic neuropathic pain, announced that the Board of Directors has appointed Thomas “Tom” West as President and Chief Executive Officer....
19. Juli 2022

Gilde Healthcare bolsters its Private Equity team in Frankfurt office

Dutch sector specialist Gilde Healthcare announces two new hires to its private equity team in Germany, following the recent close of its new €518m lower mid-market fund Gilde Healthcare Private Equity IV. With the recruitment...
12. Juli 2022